Plantman (Drug Discovery) Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Plantman (Drug Discovery) General Information
Description
Developer of plant-derived therapeutic candidates designed to treat Huntington's disease and other neurodegenerative disorders. The company leverages a proprietary plant-derived protein mechanism that directly blocks toxic protein aggregation enabling the development of novel treatments for Huntington's disease and other age-related protein aggregation disorders.
Contact Information
Website
plantman.notion.siteCorporate Office
- Zulpicherstrasse 47B
- 50674 Cologne
- Germany
Corporate Office
- Zulpicherstrasse 47B
- 50674 Cologne
- Germany
Plantman (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 02-Jul-2025 | Completed | Startup |
Plantman (Drug Discovery) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Science4Life | Accelerator/Incubator |
Plantman (Drug Discovery) FAQs
-
Where is Plantman (Drug Discovery) headquartered?
Plantman (Drug Discovery) is headquartered in Cologne, Germany.
-
What industry is Plantman (Drug Discovery) in?
Plantman (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Plantman (Drug Discovery) a private or public company?
Plantman (Drug Discovery) is a Private company.
-
What is Plantman (Drug Discovery)’s current revenue?
The current revenue for Plantman (Drug Discovery) is .
-
Who are Plantman (Drug Discovery)’s investors?
Science4Life has invested in Plantman (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process